Considerations on the Role of Pembrolizumab Adjuvant Therapy in AJCC-8 Stage IIIA Melanoma
Hindié E(1).
Author information:
(1)Elif Hindi00B4 e, MD, PhD, Department of Nuclear Medicine, Bordeaux University
Hospital, Bordeaux, France.
DOI: 10.1200/JCO.20.03213
PMID: 33492983